NuVasive | Ativo Circulante



Ativo Circulante Alterar Data
Abbott USD 24.84B 371M 2025-09
AtriCure USD 301.11M 29.85M 2025-09
Baxter International USD 6.87B 61M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Boston Scientific USD 8.04B 914M 2025-09
Cooper Companies USD 2.11B 31.4M 2025-09
Dexcom USD 4.03B 1.19B 2025-12
Edwards Lifesciences USD 6.36B 218.3M 2025-09
Globus Medical USD 1.92B 194.46M 2025-09
Haemonetics USD 943.67M 43.99M 2025-12
Hologic USD 3.84B 175.3M 2025-12
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.86B 420.3M 2025-09
Integra LifeSciences USD 1.14B 754K 2025-09
Intuitive Surgical USD 12.4B 927.3M 2025-12
J&J USD 55.62B 1.01B 2025-12
Medtronic USD 23.22B 591M 2025-06
Merit Medical Systems USD 985.53M 62.46M 2025-09
Orthofix International USD 394.17M 1.66M 2025-09
Stryker USD 14.76B 1.04B 2025-12
Tandem Diabetes Care USD 616.94M 2.13M 2025-09
Teleflex USD 1.99B 262.12M 2025-09
Zimmer Biomet Holdings USD 5.12B 715M 2025-12


NuVasive Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.